These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1973883)

  • 21. Inhibition of human gastric secretion by ICI 162,846--a new histamine H2-receptor antagonist.
    Wilson JA; Johnston DA; Penston J; Wormsley KG
    Br J Clin Pharmacol; 1986 Jun; 21(6):685-9. PubMed ID: 2874823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of pKB values for histamine H2-receptor antagonists using an in vitro acid secretion assay.
    Angus JA; Black JW; Stone M
    Br J Pharmacol; 1980 Mar; 68(3):413-23. PubMed ID: 6132635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histamine-2 receptor antagonists.
    Kumar P; Yachha SK; Misra S; Mehta S
    Indian Pediatr; 1992 Aug; 29(8):1019-23. PubMed ID: 1360945
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effects of preoperative drinking and H2 blocker on gastric acid secretion].
    Suzuki A; Kumano H; Osaka S; Shiomi Y; Moroi K; Ishimura N; Nishiwada M
    Masui; 1996 Apr; 45(4):445-8. PubMed ID: 8725599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog.
    Daly MJ; Humphray JM; Stables R
    Br J Pharmacol; 1981 Jan; 72(1):55-60. PubMed ID: 6112035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H2-receptor antagonist non-responders.
    Chiverton SG; Hunt RH
    Lancet; 1988 Jul; 2(8605):275. PubMed ID: 2899255
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal of the tolerance phenomenon by the intermittent administration of a histamine H2-receptor antagonist.
    Takahashi M; Katayama Y
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1493-7. PubMed ID: 20796145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the effects of anti-secretory drugs on intragastric acidity: is combined therapy with a proton pump inhibitor and an H2 receptor antagonist effective as initial treatment?
    Inamori M; Togawa J; Chiguchi G; Abe Y; Kikuchi T; Muramatsu K; Kawamura H; Kobayashi N; Kirikoshi H; Shimamura T; Sakaguchi T; Takamura T; Ueno N; Nakajima A
    J Gastroenterol; 2005 Feb; 40(2):213-4. PubMed ID: 15770408
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case report. H2-antagonist efficient against drug-related weight gain].
    Eriksson H
    Lakartidningen; 2000 Jun; 97(23):2869. PubMed ID: 10885224
    [No Abstract]   [Full Text] [Related]  

  • 30. [H2-blockers in the pediatric practice: is the potential exhausted?].
    Bel'mer SV; Kovalenko AA; Gasilina TV
    Eksp Klin Gastroenterol; 2005; (6):19-22. PubMed ID: 17378381
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of ranitidine (inhibitor of H2 receptors) after i.v. injection to patients treated in an intensive care unit: control of gastric acid secretion and estimation of drug plasma levels.
    Macchi H; Fiasse R; Reynaert M; Desager JP; Dive C
    Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):306-7. PubMed ID: 6125133
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of Wy-45,727 on 24 h intragastric acidity in twenty normal volunteers.
    Merki HS; Kaufmann D; Kempf M; Mappes A; Heim J; Roehmel J; Walt RP
    Br J Clin Pharmacol; 1989 Feb; 27(2):135-8. PubMed ID: 2565728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Various problems on refractory peptic ulcers; ulcers resistant to therapy with H2-receptor antagonists--therapeutic countermeasures].
    Itoh M
    Nihon Rinsho; 1988 Jan; 46(1):140-5. PubMed ID: 2897483
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
    Ozawa T; Yoshikawa N; Tomita T; Akita Y; Mitamura K
    J Gastroenterol; 2003; 38(9):844-8. PubMed ID: 14564629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Achieving pH control in the critically ill patient: the role of continuous infusion of H2-receptor antagonists.
    Moore JG
    DICP; 1990 Nov; 24(11 Suppl):S28-30. PubMed ID: 1980180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acid suppression: how much is needed?
    Colin-Jones DG
    BMJ; 1990 Sep; 301(6752):564-5. PubMed ID: 1978697
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of aspirin-induced gastric mucosal injury by histamine H2 receptor antagonists: a crossover endoscopic and intragastric pH study in the dog.
    Cavanagh RL; Buyniski JP; Schwartz SE
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1179-84. PubMed ID: 2891837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gastric acid secretion and histamine H2 receptor antagonists].
    Gespach C; Emami S; Di Gioia Y; Chastre E
    Gastroenterol Clin Biol; 1990; 14(12):982-94. PubMed ID: 1981198
    [No Abstract]   [Full Text] [Related]  

  • 39. L-643.441: an H2-receptor antagonist with potent and long-lasting effects in man.
    Henry DA; Somerville KW; Kitchingman GK; Holmes IB; Tobert JA; Langman MJ
    Br J Clin Pharmacol; 1985 Aug; 20(2):133-6. PubMed ID: 2864050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histamine H2-receptor antagonists.
    Keithley JK
    Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.